Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey

[1]  S. Jamshed,et al.  Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review , 2021, Current medical research and opinion.

[2]  L. Kubilienė,et al.  Adverse Drug Reaction Reporting by Patients in 12 European Countries , 2021, International journal of environmental research and public health.

[3]  H. Rahman,et al.  Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education , 2020, Therapeutic advances in drug safety.

[4]  Kruger Paola,et al.  The value of direct patient reporting in pharmacovigilance , 2020, Therapeutic advances in drug safety.

[5]  P. Ekmekci,et al.  Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians? , 2019, Turkiye Klinikleri Journal of Medical Ethics-Law and History.

[6]  S. Straus,et al.  Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action , 2018, Drug Safety.

[7]  M. Hayran,et al.  Spontaneous Reporting of Adverse Drug Reactions by Consumers in Comparison with Healthcare Professionals in Turkey from 2014 to 2016 , 2018, Pharmaceutical Medicine.

[8]  N. D. Aydınkarahaliloğlu,et al.  Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation , 2016, Drugs - Real World Outcomes.

[9]  M. Lindquist,et al.  Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum , 2014, Drug Safety.

[10]  S. Pal,et al.  WHO programme for international drug monitoring , 2013 .

[11]  Ebba Holme Hansen,et al.  Global Patterns of Adverse Drug Reactions Over a Decade , 2012, Drug Safety.

[12]  Lise Aagaard,et al.  Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. , 2012, Drug safety.